1. AHRO : Austin Health Research Online

Jonathan S Cebon

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Jonathan S Cebon
Full Name
Cebon, Jonathan S
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Cebon, Jonathan S
Author:  Woods, Katherine

Results 1-12 of 12 (Search time: 0.007 seconds).

Publication YearTitleAuthor(s)
19-Apr-2021Ropporin-1 and 1B Are Widely Expressed in Human Melanoma and Evoke Strong Humoral Immune Responses.Da Gama Duarte, Jessica; Woods, Katherine; Quigley, Luke T; Deceneux, Cyril; Tutuka, Candani; Witkowski, Tom ; Ostrouska, Simone; Hudson, Chris; Tsao, Simon Chang-Hao; Pasam, Anupama; Dobrovic, Alexander ; Blackburn, Jonathan M; Cebon, Jonathan S ; Behren, Andreas
216-Sep-2020Spliced Peptides and Cytokine-Driven Changes in the Immunopeptidome of Melanoma.Faridi, Pouya; Woods, Katherine; Ostrouska, Simone; Deceneux, Cyril; Aranha, Ritchlynn; Duscharla, Divya; Wong, Stephen Q; Chen, Weisan; Ramarathinam, Sri H; Lim Kam Sian, Terry C C; Croft, Nathan P; Li, Chen; Ayala, Rochelle; Cebon, Jonathan S ; Purcell, Anthony W; Schittenhelm, Ralf B; Behren, Andreas
37-Feb-2020Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells.Rigau, Marc; Ostrouska, Simone; Fulford, Thomas S; Johnson, Darryl N; Woods, Katherine; Ruan, Zheng; McWilliam, Hamish E G; Hudson, Christopher; Tutuka, Candani; Wheatley, Adam K; Kent, Stephen J; Villadangos, Jose A; Pal, Bhupinder; Kurts, Christian; Simmonds, Jason; Pelzing, Matthias; Nash, Andrew D; Hammet, Andrew; Verhagen, Anne M; Vairo, Gino; Maraskovsky, Eugene; Panousis, Con; Gherardin, Nicholas A; Cebon, Jonathan S ; Godfrey, Dale I; Behren, Andreas; Uldrich, Adam P
46-Nov-2018Isolation and characterization of NY-ESO-1-specific T cell receptors restricted on various MHC molecules.Bethune, Michael T; Li, Xiao-Hua; Yu, Jiaji; McLaughlin, Jami; Cheng, Donghui; Mathis, Colleen; Moreno, Blanca Homet; Woods, Katherine; Knights, Ashley J; Garcia-Diaz, Angel; Wong, Stephanie; Hu-Lieskovan, Siwen; Puig-Saus, Cristina; Cebon, Jonathan S ; Ribas, Antoni; Yang, Lili; Witte, Owen N; Baltimore, David
52018Autoantibodies May Predict Immune-Related Toxicity: Results from a Phase I Study of IntralesionalBacillus Calmette-Guérinfollowed by Ipilimumab in Patients with Advanced Metastatic Melanoma.Da Gama Duarte, Jessica; Parakh, Sagun ; Andrews, Miles C; Woods, Katherine; Pasam, Anupama; Tutuka, Candani; Ostrouska, Simone; Blackburn, Jonathan M; Behren, Andreas; Cebon, Jonathan S 
62017CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity.Burr, Marian L; Sparbier, Christina E; Chan, Yih-Chih; Williamson, James C; Woods, Katherine; Beavis, Paul A; Lam, Enid Y N; Henderson, Melissa A; Bell, Charles C; Stolzenburg, Sabine; Gilan, Omer; Bloor, Stuart; Noori, Tahereh; Morgens, David W; Bassik, Michael C; Neeson, Paul J; Behren, Andreas; Darcy, Phillip K; Dawson, Sarah-Jane; Voskoboinik, Ilia; Trapani, Joseph A; Cebon, Jonathan S ; Lehner, Paul J; Dawson, Mark A
720-Jan-2015Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma.Wong, Stephen Q; Behren, Andreas; Mar, Victoria J; Woods, Katherine; Li, Jason; Sheppard, Karen E; Wolfe, Rory; Kelly, John; Cebon, Jonathan S ; Dobrovic, Alexander ; McArthur, Grant A
817-Dec-2014Effects of epithelial to mesenchymal transition on T cell targeting of melanoma cells.Woods, Katherine; Pasam, Anupama; Jayachandran, Aparna; Andrews, Miles C; Cebon, Jonathan S 
93-Jul-2014The kinase inhibitors dabrafenib and trametinib affect isolated immune cell populations.Vella, Laura J; Andrews, Miles C; Pasam, Anupama; Woods, Katherine; Behren, Andreas; Cebon, Jonathan S 
1017-Jun-2014Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.Vella, Laura J; Andrews, Miles C; Behren, Andreas; Cebon, Jonathan S ; Woods, Katherine
111-Jun-2014Evolving role of tumor antigens for future melanoma therapies.Andrews, Miles C; Woods, Katherine; Cebon, Jonathan S ; Behren, Andreas
1217-Jul-2013Tumor-specific T-cell help is associated with improved survival in melanoma.Woods, Katherine; Cebon, Jonathan S